Tag: immuno-oncology

February 25, 2019

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results

CRISPR Therapeutics (NASDAQ:CRSP) has announced financial results for its fourth quarter and full year ended December 31, 2018. As quoted...
January 29, 2019

Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
January 24, 2019

Jeff Bockman: The State and Future of Immunotherapies

Jeff Bockman with Cello Health Bioconsulting dives into the immunotherapy industry, from what’s going on now to what’s to come.
December 26, 2018

5 Top Genetics News Stories of 2018

What caught the attention of readers in the genetics market this year? We've compiled a list of our top genetics...
December 19, 2018

Biotech Outlook 2019: Will the Pressure Continue?

With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in...
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
October 18, 2018

Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China

Cancer Genetics (Nasdaq:CGIX) a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced...